From: In silico work flow for scaffold hopping in Leishmania
Protein | Inhibitor | ZINC code | Approved drug (drug bank code) | Similarity score |
---|---|---|---|---|
Pteridine | i1 | ZINC34515729 | Triamterene (DB00384) | 0.78 |
Reductase 1 | i1 | ZINC01566881 | “ | 0.96 |
 | i1 | ZINC22012802 | Pralatrexate (DB06813) | 0.73 |
 | i1 | ZINC22012807 | “ | 0.73 |
 | i1 | ZINC22012811 | “ | 0.75 |
 | i1,i3 | ZINC22012815 | “ | 0.75 |
Trypanothione Reductase | i7 | ZINC01600860 | Primaquine (DB01087) | 0.84 |
Deoxyuridine | i18 | ZINC29396021 | Lidocaine (DB00281) | 0.80 |
Triphosphatase Nucleotido hydrolase | Â | ZINC29396021 | Tocainide (DB01056) | 0.72 |
Nonspecific | i19 | ZINC77302460 | Acarbose (DB00284) | 0.98 |
Nucleoside | i21 | ZINC03872643 | Mannitol (DB00742) | 1.0 |
Hydrolase | i21 | ZINC64219378 | CalciumGluceptate (DB00326) | 0.70 |
 | i21 | ZINC13361972 | Nelarabine (DB01280) | 0.76 |
i21 | ZINC13361972 | Didanosine (DB00900) | 0.76 | |
i21 | ZINC13361972 | Vidarabine (DB00194) | 0.76 | |
i22 | ZINC08214767 | Kanamycin (DB01172) | 1.0 | |
i22 | ZINC43758958 | “ | 0.85 | |
i22 | ZINC08214767 | Tobramycin (DB00684) | 0.96 | |
i22 | ZINC43758958 | “ | 0.88 | |
i22 | ZINC08214767 | Neomycin (Db00094) | 0.94 | |
i22 | ZINC43758958 | “ | 0.88 | |
i22 | ZINC08214767 | Framycetin (DB00452) | 0.94 | |
i22 | ZINC43758958 | “ | 0.88 | |
i22 | ZINC08214767 | Paromomycin (DB01421) | 0.94 | |
i22 | ZINC43758958 | “ | 0.88 | |
i22 | ZINC08214767 | Gentamicin (DB00798) | 0.76 | |
i22 | ZINC70672630 | “ | 0.77 | |
i22 | ZINC08214767 | Glucosamine(DN01296) | 0.74 | |
i22 | ZINC43758958 | “ | 0.88 | |
i22 | ZINC70672630 | Netilmicin (DB00955) | 0.71 | |
i23 | ZINC11616582 | Pitavastatin (DB08860) | 1.0 | |
i24 | ZINC01876281 | Dyphylline (DB00651) | 0.71 |